Assignee
HISTOGEN INC
US7 patents
Top patents by PatentIndex Score
US11274276B2Mar 15, 2022
Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions
HISTOGEN INC0 citations60
US9512403B2Dec 6, 2016
Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions for methods of treating tissue injury
HISTOGEN INC1 citations60
US11597703B2Mar 7, 2023
Caspase inhibitors and methods of use thereof
HISTOGEN INC0 citations56
US11447497B2Sep 20, 2022
(S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases
HISTOGEN INC0 citations51
US10538736B2Jan 21, 2020
Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions
HISTOGEN INC0 citations49
US10143708B2Dec 4, 2018
Extracellular matrix compositions for the treatment of cancer
HISTOGEN INC0 citations49
US9506038B2Nov 29, 2016
Extracellular matrix compositions for the treatment of cancer
HISTOGEN INC0 citations49